cefamandole and Hemorrhage

cefamandole has been researched along with Hemorrhage* in 2 studies

Trials

1 trial(s) available for cefamandole and Hemorrhage

ArticleYear
Effects of cefamandole on hemostasis in patients undergoing hip replacement with heparin prophylaxis.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:6

    The aim of this study was to compare the effects of the prophylactic use of cefamandole versus oxacillin plus gentamicin on hemostasis in patients undergoing hip replacement with heparin prophylaxis. Twenty-four patients with a normal hemostatic profile were randomly allocated to receive either cefamandole or oxacillin plus gentamicin. All the patients received calcium heparin. Platelet count, bleeding time, prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin clotting time (TCT), fibrinogen and serum FDP were assessed before treatment and every day of antibiotic administration. Surgical bleeding was assessed using a four-grade score system. Platelet count, bleeding time, fibrinogen and serum FDP did not show any change with both treatments. PT, aPTT and TCT showed a similar and mild prolongation in the two groups of patients. No difference in the surgical bleeding was observed between the two groups. We conclude that a short-term prophylaxis with cefamandole is a safe regimen in patients undergoing hip replacement with heparin prophylaxis.

    Topics: Aged; Anti-Bacterial Agents; Cefamandole; Female; Hemorrhage; Hemostasis; Heparin; Hip Prosthesis; Humans; Male; Middle Aged; Premedication

1988

Other Studies

1 other study(ies) available for cefamandole and Hemorrhage

ArticleYear
[Dangerous hypoprothrombinemic hemorrhage in antibiotic therapy].
    Helvetica chirurgica acta, 1992, Volume: 58, Issue:6

    Antibiotics can be associated with hypoprothrombinaemic haemorrhages in risk patients. Risk factors are: poor nutrition, impaired liver- or renal function, coagulation depleting medical therapy or illness. Pathogenetically there is a vitamin K deficiency with reduction of vitamin K dependent clotting factors; mainly by decreased vitamin K synthesis in intestinal bacterias. In consequence every risk patient under antibiotics should receive vitamin K prophylactically and in a parenteral way, because of unreliable resorption in gastrointestinal tract. Prothrombin-time-monitoring is essential to recognize the hypoprothrombinemia in every risk patient under antibiotics.

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Cefamandole; Diverticulitis, Colonic; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Hypoprothrombinemias; Intestinal Perforation; Male; Ornidazole; Postoperative Complications; Premedication

1992